Bioaugmentation for treatment of full-scale diethylene glycol monobutyl ether (DGBE) wastewater by Serratia sp. BDG-2

J Hazard Mater. 2016 May 15:309:20-6. doi: 10.1016/j.jhazmat.2016.01.076. Epub 2016 Feb 1.

Abstract

A novel bacterial strain BDG-2 was isolated and used to augment the treatment of silicon plate manufacturing wastewater that primarily contains diethylene glycol monobutyl ether (DGBE). BDG-2 was identified as a Serratia sp. Under the optimal conditions of 30 °C, pH 9 and DGBE concentration of 2000 mg L(-1), the bioaugmented system achieved 96.92% COD removal after 39.9h. Laboratory-scale technological matching results indicated that, in a biofilm process with the addition of 100 mg L(-1) ammonia and 5 mg L(-1) total phosphorus (TP), 70.61% COD removal efficiency could be obtained in 46 h. Addition of polyaluminium chloride (PAC) to the reactors during the suspension process enhanced the settleability of the BDG-2 culture. Subsequently, successful start-up and stable operation of a full-scale bioaugmented treatment facilities were accomplished, and the volumetric organic load in the plug-flow aeration tank was 2.17 ± 0.81 kg m(-3) d(-1). The effluent COD of the facilities was stable and always below 100 mg L(-1).

Keywords: Bioaugmentation; Diethylene glycol monobutyl ether (DGBE); Engineering application; Recalcitrant organics; Silicon plate manufacturing wastewater.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bioreactors*
  • Ethylene Glycols / metabolism*
  • Industrial Waste
  • Serratia / isolation & purification
  • Serratia / metabolism*
  • Silicon
  • Waste Disposal, Fluid / methods
  • Wastewater
  • Water Pollutants, Chemical / metabolism*

Substances

  • Ethylene Glycols
  • Industrial Waste
  • Waste Water
  • Water Pollutants, Chemical
  • butyl carbitol
  • Silicon